US exempts Indian pharmaceuticals from tariffs, recognizing vital role in global healthcare, strengthening India's position as a key provider.
In a significant development, the United States has granted exemption to Indian pharmaceuticals from tariffs imposed by President Trump, acknowledging their vital co
In a significant development, the United States has granted exemption to Indian pharmaceuticals from tariffs imposed by President Trump, acknowledging their vital contribution to global healthcare. This exemption underscores India's status as a major supplier of cost-effective generic drugs. Both countries emphasize the strategic value of their trade ties, with the exemption presenting India with opportunities to boost its pharmaceutical industry.